A 10-12 Week Study to Evaluate the Safety and Efficacy of 320 mg Valsartan and 80 mg Simvastatin in Combination and as Monotherapies in Treating Hypertension and Hypercholesterolemia
type: MedicalStudy
description: A 10-12 Week Multicenter, Double-blind Study to Evaluate the Efficacy and Safety of the Combination of Valsartan (320 mg) and Simvastatin (80 mg) Compared to Valsartan (320 mg) and Simvastatin (80 mg) Monotherapies in Essential Hypertension and Hypercholesterolemia
status: COMPLETED
study design: INTERVENTIONAL
phase: PHASE3
start date: 2004-09
license: https://creativecommons.org/publicdomain/zero/1.0/
source: https://clinicaltrials.gov/study/NCT00171093
source organization: US National Library of Medicine
publisher: AI Analytics
sponsor: Novartis
study subject: HYPERTENSION
study subject: HYPERCHOLESTEROLEMIA
keywords: PHASE3
keywords: INTERVENTIONAL
keywords: COMPLETED
keywords: HYPERTENSION
keywords: HYPERCHOLESTEROLEMIA

AI Analytics
type: Organization